APOE and myeloid sarcoma: Of importance, a recent study by our research group revealed that the E2 allele of the apolipoprotein E (ApoE) gene is associated with higher MS risk in pediatric patients compared to both adult patients and controls [16], suggesting that besides the mostly common genetic backgrounds, AOMS and POMS, distinct gene variants may drive the clinical differences between these two MS entities.